The stock of 180 Life Sciences Corp (ATNF) has gone down by -3.65% for the week, with a -25.21% drop in the past month and a -9.12% drop in the past quarter. The volatility ratio for the week is 12.87%, and the volatility levels for the past 30 days are 9.29% for ATNF. The simple moving average for the past 20 days is -13.36% for ATNF’s stock, with a -51.44% simple moving average for the past 200 days.
Is It Worth Investing in 180 Life Sciences Corp (NASDAQ: ATNF) Right Now?
Company’s 36-month beta value is 0.21.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy”, 0 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for ATNF is 2.69M, and currently, short sellers hold a 1.43% ratio of that floaft. The average trading volume of ATNF on July 08, 2025 was 133.73K shares.
ATNF stock’s latest price update
The stock of 180 Life Sciences Corp (NASDAQ: ATNF) has decreased by -9.19% when compared to last closing price of $0.88.Despite this, the company has seen a loss of -3.65% in its stock price over the last five trading days. accessnewswire.com reported 2025-07-01 that PALO ALTO, CA / ACCESS Newswire / July 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) (“180” or the “Company), an innovative biotechnology company that is currently pivoting to the global iGaming sector, today announced two significant value enhancements to its existing, legacy intellectual property (“IP”) portfolio-reinforcing part of the Company’s strategy relating to continuing to build shareholder value through scientific innovation and patent protection for legacy IP assets. These new developments reflect 180’s ongoing efforts to secure strong IP rights for its novel IP, while also positioning these assets for potential future partnering, licensing, or strategic transactions aimed at maximizing value for shareholders while the Company focuses on the global iGaming sector.
Analysts’ Opinion of ATNF
Many brokerage firms have already submitted their reports for ATNF stocks, with Maxim Group repeating the rating for ATNF by listing it as a “Buy”. The predicted price for ATNF in the upcoming period, according to Maxim Group is $11 based on the research report published on September 15, 2021 of the previous year 2021.
ATNF Trading at -20.58% from the 50-Day Moving Average
After a stumble in the market that brought ATNF to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.49% of loss for the given period.
Volatility was left at 9.29%, however, over the last 30 days, the volatility rate increased by 12.87%, as shares sank -23.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.12% lower at present.
During the last 5 trading sessions, ATNF fell by -3.65%, which changed the moving average for the period of 200-days by -56.30% in comparison to the 20-day moving average, which settled at $0.9230. In addition, 180 Life Sciences Corp saw -51.53% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of 180 Life Sciences Corp, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for ATNF
The total capital return value is set at -0.86%. Equity return is now at value -221.23%, with -98.96% for asset returns.
Based on 180 Life Sciences Corp (ATNF), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -8.77. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -209.45.
Currently, EBITDA for the company is -6.32 million with net debt to EBITDA at 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
In a nutshell, 180 Life Sciences Corp (ATNF) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
